Concord Drugs Share Price
07 Aug, 2026 4:00 PM (IST)
Concord Drugs Performance
- Today's Low
- ₹71
- Today's High
- ₹73
- 52 Week Low
- ₹49
- 52 Week High
- ₹93
- Open Price₹72
- Previous Close₹73
- Volume2,577
- 50 DMA₹74.20
- 100 DMA₹75.60
- 200 DMA₹73.10
Concord Drugs Chart
Investment Returns
- Over 1 Month -5.56%
- Over 3 Month -13.84%
- Over 6 Month -8.73%
- Over 1 Year + 30.06%
Smart Investing Starts Here Start SIP with Concord Drugs for Steady Growth!
Concord Drugs Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 88.9
- PEG Ratio
- 0.4
- Market Cap Cr
- 94
- P/B Ratio
- 1.9
- Average True Range
- 4.5
- EPS
- 0.8
- Dividend Yield
- 0
- MACD Signal
- -0.7
- RSI
- 46.72
- MFI
- 42.46
Latest Stock News Updates
Concord Drugs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/08/2026 ,inter alia, to consider and approve Quarterly Results
- BSE India
- 4 days 8 hours ago
Certificate under Reg 74(5) of SEBI (DP) Regulations
- BSE India
- 3 weeks 4 days ago
Closure of Trading Window
- BSE India
- 1 month 1 week ago
Concord Drugs Financials
Concord Drugs Technicals
EMA & SMA
- Bearish Moving Average 15
- Bullish Moving Average 1
- 20 Day
- ₹72.00
- 50 Day
- ₹74.20
- 100 Day
- ₹75.60
- 200 Day
- ₹73.10
Resistance and Support
- R3 74.20
- R2 73.60
- R1 72.40
- S1 70.60
- S2 70.00
- S3 68.80
Concord Drugs Corporate Actions - Bonus, Splits, Dividends
| Date | Purpose | Remarks |
|---|---|---|
| 2026-08-10 | Quarterly Results | |
| 2026-05-27 | Audited Results | |
| 2026-02-14 | Quarterly Results | |
| 2025-11-13 | Quarterly Results | |
| 2025-08-08 | Quarterly Results |
About Concord Drugs
Concord Drugs is to manufacture licensed drugs based on the formulations approved. View More- NSE Symbol
- CONCORD
- BSE Symbol
- 538965
- ISIN
- INE858L01010
Similar Stocks to Concord Drugs
Popular Stocks
Concord Drugs FAQs
Concord Drugs share price is ₹71 As on 08 August, 2026 | 01:49
The Market Cap of Concord Drugs is ₹93.8 Cr As on 08 August, 2026 | 01:49
The P/E ratio of Concord Drugs is 88.9 As on 08 August, 2026 | 01:49
The PB ratio of Concord Drugs is 1.9 As on 08 August, 2026 | 01:49
The 52 week High & Low of Concord Drugs is ₹92.5/₹49 respectively As on 08 August, 2026 | 01:49
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.